Naratriptan is a migraine drug that river veins around the cerebrum. Naratriptan additionally diminishes substances in the body that can trigger cerebral pain torment, affectability to light and sound, and other headache manifestations.
Naratriptan is utilized to treat headache migraines. Naratriptan will just treat a migraine that has as of now started. It won’t forestall cerebral pains or diminish the quantity of assaults.
Naratriptan ought not be utilized to treat a typical strain cerebral pain, a migraine that causes loss of development on one side of your body, or any cerebral pain that is by all accounts not the same as your standard headache migraines.
Submit your review
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Stop using naratriptan and call your doctor at once if you have:
fast or pounding heartbeats;
numbness or tingling and a pale or blue-colored appearance in your fingers or toes;
pain or heavy feeling in your legs, hip pain, burning pain in your feet;
sudden and severe stomach pain, bloody diarrhea, constipation, fever, weight loss;
dangerously high blood pressure--severe headache, blurred vision, pounding in your neck or ears, nosebleed, anxiety, confusion, severe chest pain, shortness of breath, irregular heartbeats, seizure;
heart attack symptoms--chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating; or
signs of a stroke--sudden numbness or weakness (especially on one side of the body), sudden severe headache, slurred speech, problems with vision or balance.
Common side effects may include:
feeling weak or tired;
numbness or tingling;
flushing (warmth, redness, or tingly feeling);
pain or tightness in your jaw, neck, or throat.
The recommended dose of AMERGE is 1 mg or 2.5 mg. If the migraine returns or if the patient has only partial response, the dose may be repeated once after 4 hours, for a maximum dose of 5 mg in a 24-hour period. The safety of treating an average of more than 4 migraine attacks in a 30‑day period has not been established.